Fortis Healthcare Share Price
Sector: Healthcare Facilities
634.50 -14.65 (-2.26%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
521.05
Today’s High
638.70
52 Week Low
406.35
52 Week High
744.00
633.35 -16.10 (-2.48%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
595.80
Today’s High
640.00
52 Week Low
406.00
52 Week High
744.50
Key Metrics
- Market Cap (In Cr) 47968.9
- Beta 1.1
- Div. Yield (%) 0.15
- P/B 6.4
- TTM P/E 70.7
- Peg Ratio -
- Sector P/E 22.43
- Open Price 521.05
- Prev Close 649.15
Fortis Healthcare Analysis
Price Analysis
-
1 Week-3.33%
-
3 Months-11.28%
-
6 Month11.7%
-
YTD-9.78%
-
1 Year52.67%
Risk Meter
- 37% Low risk
- 37% Moderate risk
- 37% Balanced Risk
- 37% High risk
- 37% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 4
- 4
- 4
- 4
- Buy
- 8
- 8
- 8
- 8
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 1
- 1
- 1
- 1
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 13
- 13
- 13
- 13
Fortis Healthcare News
Top stock picks: Market experts recommend these stocks to buy today
2 min read . 01 Apr 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 01 Apr 2025Fortis Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 6892.92
- Selling/ General/ Admin Expenses Total
- 3764.77
- Depreciation/ Amortization
- 342.5
- Other Operating Expenses Total
- 11.77
- Total Operating Expense
- 5951.4
- Operating Income
- 941.51
- Net Income Before Taxes
- 857.97
- Net Income
- 598.88
- Diluted Normalized EPS
- 7.74
- Period
- 2024
- Total Assets
- 13288.78
- Total Liabilities
- 5625.88
- Total Equity
- 7662.9
- Tangible Book Valueper Share Common Eq
- 40.47
- Period
- 2024
- Cashfrom Operating Activities
- 1100.1
- Cashfrom Investing Activities
- -886.37
- Cashfrom Financing Activities
- -86.46
- Net Changein Cash
- 124.52
- Period
- 2023
- Total Revenue
- 6297.63
- Selling/ General/ Admin Expenses Total
- 3504.95
- Depreciation/ Amortization
- 315.74
- Other Operating Expenses Total
- 11.43
- Total Operating Expense
- 5438.42
- Operating Income
- 859.22
- Net Income Before Taxes
- 813.68
- Net Income
- 588.73
- Diluted Normalized EPS
- 6.87
- Period
- 2023
- Total Assets
- 12433.6
- Total Liabilities
- 5191.34
- Total Equity
- 7242.26
- Tangible Book Valueper Share Common Eq
- 35.3
- Period
- 2023
- Cashfrom Operating Activities
- 822.23
- Cashfrom Investing Activities
- -373.7
- Cashfrom Financing Activities
- -471.22
- Net Changein Cash
- -21.46
- Period
- 2022
- Total Revenue
- 5717.61
- Selling/ General/ Admin Expenses Total
- 3063.26
- Depreciation/ Amortization
- 300.84
- Other Operating Expenses Total
- 11.16
- Total Operating Expense
- 4642.55
- Operating Income
- 1075.06
- Net Income Before Taxes
- 987.79
- Net Income
- 555.12
- Diluted Normalized EPS
- 3.98
- Period
- 2022
- Total Assets
- 11884.75
- Total Liabilities
- 5706.51
- Total Equity
- 6178.24
- Tangible Book Valueper Share Common Eq
- 22.69
- Period
- 2022
- Cashfrom Operating Activities
- 879.11
- Cashfrom Investing Activities
- -514.38
- Cashfrom Financing Activities
- -517.31
- Net Changein Cash
- -152.52
- Period
- 2021
- Total Revenue
- 4030.12
- Selling/ General/ Admin Expenses Total
- 2424.81
- Depreciation/ Amortization
- 290.6
- Other Operating Expenses Total
- 24.06
- Total Operating Expense
- 3902.96
- Operating Income
- 127.16
- Net Income Before Taxes
- 43.3
- Net Income
- -109.76
- Diluted Normalized EPS
- -1.48
- Period
- 2021
- Total Assets
- 11154.69
- Total Liabilities
- 5034.88
- Total Equity
- 6119.81
- Tangible Book Valueper Share Common Eq
- 30.92
- Period
- 2021
- Cashfrom Operating Activities
- 485.49
- Cashfrom Investing Activities
- -135.1
- Cashfrom Financing Activities
- -142.93
- Net Changein Cash
- 212.01
- Period
- 2020
- Total Revenue
- 4632.32
- Selling/ General/ Admin Expenses Total
- 2841.78
- Depreciation/ Amortization
- 291.73
- Other Operating Expenses Total
- 13.72
- Total Operating Expense
- 4251.83
- Operating Income
- 380.49
- Net Income Before Taxes
- 239.36
- Net Income
- 57.94
- Diluted Normalized EPS
- 0.24
- Period
- 2020
- Total Assets
- 11347.82
- Total Liabilities
- 4686.73
- Total Equity
- 6661.09
- Tangible Book Valueper Share Common Eq
- 37.94
- Period
- 2020
- Cashfrom Operating Activities
- 171.54
- Cashfrom Investing Activities
- 60.42
- Cashfrom Financing Activities
- -861.61
- Net Changein Cash
- -626.59
- Period
- 2019
- Total Revenue
- 4469.36
- Selling/ General/ Admin Expenses Total
- 3107.42
- Depreciation/ Amortization
- 231.81
- Other Operating Expenses Total
- 7.24
- Total Operating Expense
- 4686.9
- Operating Income
- -217.54
- Net Income Before Taxes
- -110.1
- Net Income
- -298.94
- Diluted Normalized EPS
- -1.84
- Period
- 2019
- Total Assets
- 11951.27
- Total Liabilities
- 5350.47
- Total Equity
- 6600.8
- Tangible Book Valueper Share Common Eq
- 36.95
- Period
- 2019
- Cashfrom Operating Activities
- -87.62
- Cashfrom Investing Activities
- -3322.74
- Cashfrom Financing Activities
- 4256.61
- Net Changein Cash
- 798.76
- Period
- 2018
- Total Revenue
- 4560.81
- Selling/ General/ Admin Expenses Total
- 3073.19
- Depreciation/ Amortization
- 235.61
- Other Operating Expenses Total
- 10.73
- Total Operating Expense
- 5371.9
- Operating Income
- -811.09
- Net Income Before Taxes
- -911.77
- Net Income
- -1009.22
- Diluted Normalized EPS
- -8.36
- Period
- 2018
- Total Assets
- 8621.69
- Total Liabilities
- 4559.97
- Total Equity
- 4061.72
- Tangible Book Valueper Share Common Eq
- 36.37
- Period
- 2018
- Cashfrom Operating Activities
- 492.9
- Cashfrom Investing Activities
- -335.37
- Cashfrom Financing Activities
- -672.05
- Net Changein Cash
- -512.6
- Period
- 2024-12-31
- Total Revenue
- 1928.26
- Selling/ General/ Admin Expenses Total
- 708.01
- Depreciation/ Amortization
- 97.33
- Other Operating Expenses Total
- 391.66
- Total Operating Expense
- 1626.67
- Operating Income
- 301.59
- Net Income Before Taxes
- 279.39
- Net Income
- 247.9
- Diluted Normalized EPS
- 2.99
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1988.39
- Selling/ General/ Admin Expenses Total
- 699.15
- Depreciation/ Amortization
- 95.05
- Other Operating Expenses Total
- 393.57
- Total Operating Expense
- 1708.38
- Operating Income
- 280.01
- Net Income Before Taxes
- 261.05
- Net Income
- 176.46
- Diluted Normalized EPS
- 2.93
- Period
- 2024-09-30
- Total Assets
- 13596.82
- Total Liabilities
- 5749.54
- Total Equity
- 7847.28
- Tangible Book Valueper Share Common Eq
- 43.09
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 531.4
- Cashfrom Investing Activities
- -307.69
- Cashfrom Financing Activities
- -315.41
- Net Changein Cash
- -91.64
- Period
- 2024-06-30
- Total Revenue
- 1858.9
- Selling/ General/ Admin Expenses Total
- 688.87
- Depreciation/ Amortization
- 91
- Other Operating Expenses Total
- 374.65
- Total Operating Expense
- 1607.18
- Operating Income
- 251.72
- Net Income Before Taxes
- 230.05
- Net Income
- 165.96
- Diluted Normalized EPS
- 2.2
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1785.88
- Selling/ General/ Admin Expenses Total
- 641.3
- Depreciation/ Amortization
- 92.23
- Other Operating Expenses Total
- 349.87
- Total Operating Expense
- 1493.94
- Operating Income
- 291.94
- Net Income Before Taxes
- 271.38
- Net Income
- 178.73
- Diluted Normalized EPS
- 2.33
- Period
- 2024-03-31
- Total Assets
- 13288.78
- Total Liabilities
- 5625.88
- Total Equity
- 7662.9
- Tangible Book Valueper Share Common Eq
- 40.47
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1100.1
- Cashfrom Investing Activities
- -886.37
- Cashfrom Financing Activities
- -86.46
- Net Changein Cash
- 124.52
- Period
- 2023-12-31
- Total Revenue
- 1679.68
- Selling/ General/ Admin Expenses Total
- 644.73
- Depreciation/ Amortization
- 86.91
- Other Operating Expenses Total
- 357.21
- Total Operating Expense
- 1474.91
- Operating Income
- 204.77
- Net Income Before Taxes
- 183.15
- Net Income
- 134.67
- Diluted Normalized EPS
- 1.71
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 1769.95
- Selling/ General/ Admin Expenses Total
- 654.97
- Depreciation/ Amortization
- 84.12
- Other Operating Expenses Total
- 372.08
- Total Operating Expense
- 1520.21
- Operating Income
- 249.74
- Net Income Before Taxes
- 232.71
- Net Income
- 173.72
- Diluted Normalized EPS
- 2.26
- Period
- 2023-09-30
- Total Assets
- 12785.37
- Total Liabilities
- 5175.21
- Total Equity
- 7610.16
- Tangible Book Valueper Share Common Eq
- 39.89
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 475.46
- Cashfrom Investing Activities
- -385.61
- Cashfrom Financing Activities
- -145.73
- Net Changein Cash
- -56.99
- Period
- 2023-06-30
- Total Revenue
- 1657.41
- Selling/ General/ Admin Expenses Total
- 638.04
- Depreciation/ Amortization
- 79.24
- Other Operating Expenses Total
- 348.41
- Total Operating Expense
- 1462.71
- Operating Income
- 194.7
- Net Income Before Taxes
- 170.73
- Net Income
- 111.76
- Diluted Normalized EPS
- 1.47
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 1642.7
- Selling/ General/ Admin Expenses Total
- 602.64
- Depreciation/ Amortization
- 81.78
- Other Operating Expenses Total
- 386.8
- Total Operating Expense
- 1443.07
- Operating Income
- 199.64
- Net Income Before Taxes
- 183.41
- Net Income
- 132.55
- Diluted Normalized EPS
- 1.65
- Period
- 2023-03-31
- Total Assets
- 12433.6
- Total Liabilities
- 5191.34
- Total Equity
- 7242.26
- Tangible Book Valueper Share Common Eq
- 35.3
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 822.23
- Cashfrom Investing Activities
- -373.7
- Cashfrom Financing Activities
- -471.22
- Net Changein Cash
- -21.46
- Period
- 2022-12-31
- Total Revenue
- 1559.88
- Selling/ General/ Admin Expenses Total
- 591.51
- Depreciation/ Amortization
- 82.75
- Other Operating Expenses Total
- 333.68
- Total Operating Expense
- 1354.72
- Operating Income
- 205.16
- Net Income Before Taxes
- 186.1
- Net Income
- 129.56
- Diluted Normalized EPS
- 1.6
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Fortis Healthcare Technical
Moving Average
SMA
- 5 Day671.8
- 10 Day660.39
- 20 Day639.82
- 50 Day629.4
- 100 Day655.98
- 300 Day597.48
Fortis Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Max Healthcare Institute
- 1082.9
- -52.65
- -4.64
- 1227.5
- 743
- 104962.15
- Apollo Hospitals Enterprise
- 6718
- -3.25
- -0.05
- 7545.1
- 5690.8
- 96594.53
- Fortis Healthcare
- 634.5
- -14.65
- -2.26
- 744
- 406.35
- 47968.9
- Narayana Hrudayalaya
- 1642.35
- -35.55
- -2.12
- 1725
- 1087.8
- 33533.32
- Global Health
- 1212
- -21.1
- -1.71
- 1510.1
- 936.05
- 32652.63
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Max Healthcare Institute
- 105
- 13.15
- 10.89
- 15.02
- Apollo Hospitals Enterprise
- 107.3
- 13.92
- 13.57
- 4.82
- Fortis Healthcare
- 83.91
- 6.4
- 5.07
- 7.63
- Narayana Hrudayalaya
- 42.92
- 11.89
- 23.44
- 9.72
- Global Health
- 69.42
- 11.41
- -
- -
Fortis Healthcare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 07-Feb-25
- Quarterly Results
- 08-Nov-24
- Quarterly Results
- 09-Oct-24
- Others
- 30-Aug-24
- To consider Fund Raising
- 06-Aug-24
- Quarterly Results
- 23-May-24
- Audited Results & Final Dividend
- 07-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 04-Aug-23
- Quarterly Results
- 23-May-23
- Audited Results & Final Dividend
- Meeting Date
- Announced on
- Purpose
- 22-Mar-25
- 19-Feb-25
- POM
- 07-Oct-24
- 05-Sept-24
- POM
- 02-Aug-24
- 11-Jul-24
- AGM
- 01-Apr-24
- 29-Feb-24
- POM
- 03-Jan-24
- 04-Dec-23
- POM
- 08-Dec-23
- 07-Nov-23
- POM
- 09-Sept-23
- 09-Aug-23
- POM
- 01-Aug-23
- 23-May-23
- AGM
- 01-Jul-23
- 02-Jun-23
- POM
- 01-Aug-22
- 21-Jun-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 23-May-24
- 24-Jul-24
- 24-Jul-24
- 1
- 24-May-23
- 20-Jul-23
- 20-Jul-23
- 1


